"10.1371_journal.pone.0042454","none","2012-08-14T00:00:00Z","Romina Nassini; Pamela Pedretti; Nadia Moretto; Camilla Fusi; Chiara Carnini; Fabrizio Facchinetti; Arturo Roberto Viscomi; Anna Rita Pisano; Susan Stokesberry; Charlott Brunmark; Naila Svitacheva; Lorcan McGarvey; Riccardo Patacchini; Anders B Damholt; Pierangelo Geppetti; Serena Materazzi","Department of Preclinical and Clinical Pharmacology, University of Florence, Florence, Italy; Pharmacology Department, Chiesi Farmaceutici SpA, Parma, Italy; Department of Biochemistry and Molecular Biology, University of Parma, Italy; Centre for Infection and Immunity, Queen's University Belfast, Belfast, United Kingdom; AstraZeneca Research & Development Innovative Medicines Respiratory & Inflammation, MÃ¶lndal, Sweden; Truly Translational Sweden AB, Lund, Sweden; Disease Pharmacology LEO Pharma A/S, Ballerup, Denmark; Department of Biology, University of Copenhagen, Copenhagen, Denmark; Headache Center, University of Florence, Florence, Italy","Conceived and designed the experiments: RN RP ABD PG SM. Performed the experiments: RN PP NM CF ARV ARP SS CB NS SM. Analyzed the data: RN PP NM CC CB SM. Contributed reagents/materials/analysis tools: CC ARV SS. Wrote the paper: RN FF LMG RP ABD PG SM.","CB, NS and ABD at the time when the study was performed were employees of AstraZeneca. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Currently, CB and NS are employees at Truly Translational Sweden AB, and LEO Pharma A/S, respectively, while ABD is an employee of the University of Copenhagen. PP, NM, CC, FF, ARP, RP are currently employees at Chiesi Farmaceutici SpA. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors have declared that no competing interests exist.","2012","08","Romina Nassini","RN",16,FALSE,5,10,6,7,TRUE,TRUE,FALSE,0,NA,FALSE
